MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Avanos Medical DPO Ratio 2011-2026 | AVNS
Annual DPO Ratio Avanos Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57.7 | 65.9 | 77.2 | 78.3 | 59.7 | 79.9 | 103 | 237 | 227 | 61.1 | 57.1 | 54.8 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 237 | 54.8 | 96.6 |
Quarterly DPO Ratio Avanos Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.2 | 52.2 | 58.9 | - | 62.2 | 65 | 72.5 | - | 70.7 | 79.7 | 85.7 | - | 80.3 | 84.3 | 60.4 | - | 58.5 | 56.9 | 64 | - | 68.6 | 79.9 | 87.8 | - | 99.1 | 103 | 176 | - | 257 | 234 | 238 | - | 225 | 242 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 257 | 51.2 | 108 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
48.8 | - | 1.37 % | $ 20.5 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 38.89 | -0.97 % | $ 5.8 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
81.1 | $ 8.15 | 4.28 % | $ 585 M |  Israel |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 9.67 | 2.87 % | $ 1.31 B | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 4.15 | 4.01 % | $ 155 M |  France |
 |
Electromed
ELMD
|
47.8 | $ 24.4 | 1.73 % | $ 206 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 43.12 | -0.45 % | $ 1.34 B | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 18.53 | 0.16 % | $ 121 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
34.4 | $ 29.26 | -1.91 % | $ 1.35 B | USA |
 |
Apyx Medical Corporation
APYX
|
52.8 | $ 3.34 | 5.36 % | $ 116 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | Israel |
 |
Accuray Incorporated
ARAY
|
49.2 | $ 0.52 | -0.82 % | $ 53.4 M | USA |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
125 | $ 0.79 | -1.75 % | $ 43 M | USA |
 |
Align Technology
ALGN
|
33.7 | $ 182.04 | -0.33 % | $ 13.6 B | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Inari Medical
NARI
|
58.2 | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
51.3 | $ 4.05 | 9.32 % | $ 857 M | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
79.7 | $ 113.39 | -0.17 % | $ 197 B | USA |
 |
NuVasive
NUVA
|
19.8 | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
61.7 | - | - | $ 217 M | USA |
 |
InMode Ltd.
INMD
|
72.7 | $ 13.53 | -0.51 % | $ 874 M | Israel |
 |
Boston Scientific Corporation
BSX
|
61.7 | $ 72.94 | -1.23 % | $ 108 B | USA |
 |
IRadimed Corporation
IRMD
|
40.6 | $ 105.07 | 0.75 % | $ 1.33 B | USA |
 |
IRIDEX Corporation
IRIX
|
50.7 | $ 1.42 | -0.7 % | $ 22.9 M | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 2.35 | 18.43 % | $ 1.43 M | USA |
 |
Alphatec Holdings
ATEC
|
73.8 | $ 13.05 | 0.19 % | $ 1.96 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
58.1 | $ 85.52 | 0.3 % | $ 50 B | USA |